{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:14:12Z","timestamp":1783714452553,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"43","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["28-A-11"],"award-info":[{"award-number":["28-A-11"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["29-A-2"],"award-info":[{"award-number":["29-A-2"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["2020-J-2"],"award-info":[{"award-number":["2020-J-2"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","award":["CH27066"],"award-info":[{"award-number":["CH27066"]}],"id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,10,21]]},"DOI":"10.1038\/s41388-022-02469-6","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T05:03:53Z","timestamp":1663650233000},"page":"4779-4794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ARHGAP\u2013RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1180-1746","authenticated-orcid":false,"given":"Masayuki","family":"Komatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0142-2240","authenticated-orcid":false,"given":"Hitoshi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-9157","authenticated-orcid":false,"given":"Fumiko","family":"Chiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Komatsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Asaumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Tsunoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1629-6630","authenticated-orcid":false,"given":"Hiromichi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-707X","authenticated-orcid":false,"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Matsusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9443-0364","authenticated-orcid":false,"given":"Hiroki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"2469_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2469_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31\u201349.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2469_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-58","volume":"11","author":"MZ Qiu","year":"2013","unstructured":"Qiu MZ, Cai MY, Zhang DS, Wang ZQ, Wang DS, Li YH, et al. Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China. J Transl Med. 2013;11:58.","journal-title":"J Transl Med"},{"key":"2469_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10434-999-0290-2","volume":"6","author":"W Polkowski","year":"1999","unstructured":"Polkowski W, van Sandick JW, Offerhaus GJ, ten Kate FJ, Mulder J, Obertop H, et al. Prognostic value of Lauren classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol. 1999;6:290\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2469_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00428-007-0572-7","volume":"452","author":"HC Zheng","year":"2008","unstructured":"Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, et al. Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch. 2008;452:525\u201334.","journal-title":"Virchows Arch"},{"key":"2469_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354\u201362.","journal-title":"World J Gastroenterol"},{"key":"2469_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0046-8177(81)80124-4","volume":"12","author":"I Duarte","year":"1981","unstructured":"Duarte I, Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum Pathol. 1981;12:237\u201342.","journal-title":"Hum Pathol"},{"key":"2469_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10120-006-0370-y","volume":"9","author":"K Maruyama","year":"2006","unstructured":"Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9:51\u201366.","journal-title":"Gastric Cancer"},{"key":"2469_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66637-y","volume":"10","author":"HJ Shim","year":"2020","unstructured":"Shim HJ, Kim HJ, Lee SH, Bae WK, Hwang EC, Cho SH, et al. Observational study of peritoneal washing cytology-positive gastric cancer without gross peritoneal metastasis in patients who underwent radical D2 gastrectomy. Sci Rep. 2020;10:9549.","journal-title":"Sci Rep"},{"key":"2469_CR10","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1078-0432.CCR-07-4354","volume":"14","author":"K Mimori","year":"2008","unstructured":"Mimori K, Fukagawa T, Kosaka Y, Kita Y, Ishikawa K, Etoh T, et al. Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1. Clin Cancer Res. 2008;14:2609\u201316.","journal-title":"Clin Cancer Res"},{"key":"2469_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u20139.","journal-title":"Nature"},{"key":"2469_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573\u201382.","journal-title":"Nat Genet"},{"key":"2469_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ng.2984","volume":"46","author":"M Kakiuchi","year":"2014","unstructured":"Kakiuchi M, Nishizawa T, Ueda H, Gotoh K, Tanaka A, Hayashi A, et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 2014;46:583\u20137.","journal-title":"Nat Genet"},{"key":"2469_CR14","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3389\/fonc.2020.01214","volume":"10","author":"WH Zhang","year":"2020","unstructured":"Zhang WH, Zhang SY, Hou QQ, Qin Y, Chen XZ, Zhou ZG, et al. The significance of the CLDN18-ARHGAP fusion gene in gastric cancer: a systematic review and meta-analysis. Front Oncol. 2020;10:1214.","journal-title":"Front Oncol"},{"key":"2469_CR15","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1038\/s41388-019-0963-7","volume":"38","author":"JH Svensmark","year":"2019","unstructured":"Svensmark JH, Brakebusch C. Rho GTPases in cancer: friend or foe? Oncogene. 2019;38:7447\u201356.","journal-title":"Oncogene"},{"key":"2469_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-19-0811","volume":"10","author":"H Zhang","year":"2020","unstructured":"Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Diehl JN, et al. Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer. Cancer Disco. 2020;10:288\u2013305.","journal-title":"Cancer Disco"},{"key":"2469_CR17","doi-asserted-by":"publisher","first-page":"29336","DOI":"10.18632\/oncotarget.25464","volume":"9","author":"A Tanaka","year":"2018","unstructured":"Tanaka A, Ishikawa S, Ushiku T, Yamazawa S, Katoh H, Hayashi A, et al. Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset. Oncotarget. 2018;9:29336\u201350.","journal-title":"Oncotarget"},{"key":"2469_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/cas.13967","volume":"110","author":"I Nakayama","year":"2019","unstructured":"Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, et al. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Cancer Sci. 2019;110:1352\u201363.","journal-title":"Cancer Sci"},{"key":"2469_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04907-0","volume":"9","author":"Y Shu","year":"2018","unstructured":"Shu Y, Zhang W, Hou Q, Zhao L, Zhang S, Zhou J, et al. Prognostic significance of frequent CLDN18-ARHGAP26\/6 fusion in gastric signet-ring cell cancer. Nat Commun. 2018;9:2447.","journal-title":"Nat Commun"},{"key":"2469_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06747-4","volume":"9","author":"H Yang","year":"2018","unstructured":"Yang H, Hong D, Cho SY, Park YS, Ko WR, Kim JH, et al. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer. Nat Commun. 2018;9:4439.","journal-title":"Nat Commun"},{"key":"2469_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0847-5","volume":"19","author":"XF Xu","year":"2019","unstructured":"Xu XF, Gao F, Wang JJ, Long C, Chen X, Tao L, et al. BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK\/STAT3 signaling pathway. Cancer Cell Int. 2019;19:133.","journal-title":"Cancer Cell Int"},{"key":"2469_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.celrep.2015.06.020","volume":"12","author":"F Yao","year":"2015","unstructured":"Yao F, Kausalya JP, Sia YY, Teo AS, Lee WH, Ong AG, et al. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 2015;12:272\u201385.","journal-title":"Cell Rep"},{"key":"2469_CR23","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/cells8070733","volume":"8","author":"M Bros","year":"2019","unstructured":"Bros M, Haas K, Moll L, Grabbe S. RhoA as a key regulator of innate and adaptive immunity. Cells. 2019;8:733\u201362.","journal-title":"Cells"},{"key":"2469_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1871529X18666180326120638","volume":"18","author":"JA MacDonald","year":"2018","unstructured":"MacDonald JA, Walsh MP. Regulation of smooth muscle myosin light chain phosphatase by multisite phosphorylation of the myosin targeting subunit, MYPT1. Cardiovasc Hematol Disord Drug Targets. 2018;18:4\u201313.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"2469_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"2469_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrm3431","volume":"13","author":"A Ratheesh","year":"2012","unstructured":"Ratheesh A, Yap AS. A bigger picture: classical cadherins and the dynamic actin cytoskeleton. Nat Rev Mol cell Biol. 2012;13:673\u20139.","journal-title":"Nat Rev Mol cell Biol"},{"key":"2469_CR27","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3390\/cells8101118","volume":"8","author":"CY Loh","year":"2019","unstructured":"Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8:1118\u201350.","journal-title":"Cells"},{"key":"2469_CR28","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.molcel.2014.04.029","volume":"54","author":"M Lu","year":"2014","unstructured":"Lu M, Marsters S, Ye X, Luis E, Gonzalez L, Ashkenazi A. E-cadherin couples death receptors to the cytoskeleton to regulate apoptosis. Mol Cell. 2014;54:987\u201398.","journal-title":"Mol Cell"},{"key":"2469_CR29","first-page":"2143","volume":"119","author":"A Ivanov","year":"2009","unstructured":"Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL, et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J Clin Invest. 2009;119:2143\u201359.","journal-title":"J Clin Invest"},{"key":"2469_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1083\/jcb.200706097","volume":"179","author":"Z Ma","year":"2007","unstructured":"Ma Z, Myers DP, Wu RF, Nwariaku FE, Terada LS. p66Shc mediates anoikis through RhoA. J Cell Biol. 2007;179:23\u201331.","journal-title":"J Cell Biol"},{"key":"2469_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","volume":"6","author":"N Barker","year":"2010","unstructured":"Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010;6:25\u201336.","journal-title":"Cell Stem Cell"},{"key":"2469_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nbt1310","volume":"25","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25:681\u20136.","journal-title":"Nat Biotechnol"},{"key":"2469_CR33","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrc3789","volume":"14","author":"CL Buchheit","year":"2014","unstructured":"Buchheit CL, Weigel KJ, Schafer ZT. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat Rev Cancer. 2014;14:632\u201341.","journal-title":"Nat Rev Cancer"},{"key":"2469_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.celrep.2017.06.037","volume":"20","author":"JC Hamann","year":"2017","unstructured":"Hamann JC, Surcel A, Chen R, Teragawa C, Albeck JG, Robinson DN, et al. Entosis is induced by glucose starvation. Cell Rep. 2017;20:201\u201310.","journal-title":"Cell Rep"},{"key":"2469_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/gtc.12603","volume":"23","author":"M Kumeta","year":"2018","unstructured":"Kumeta M, Panina Y, Yamazaki H, Takeyasu K, Yoshimura SH. N-terminal dual lipidation-coupled molecular targeting into the primary cilium. Genes Cells. 2018;23:715\u201323.","journal-title":"Genes Cells"},{"key":"2469_CR36","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.18632\/oncotarget.6920","volume":"7","author":"H Tomita","year":"2016","unstructured":"Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7:11018\u201332.","journal-title":"Oncotarget"},{"key":"2469_CR37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s10120-015-0525-9","volume":"19","author":"M Maeda","year":"2016","unstructured":"Maeda M, Ushijima T. RHOA mutation may be associated with diffuse-type gastric cancer progression, but is it gain or loss? Gastric Cancer. 2016;19:326\u20138.","journal-title":"Gastric Cancer"},{"key":"2469_CR38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10120-015-0493-0","volume":"19","author":"T Ushiku","year":"2016","unstructured":"Ushiku T, Ishikawa S, Kakiuchi M, Tanaka A, Katoh H, Aburatani H, et al. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Gastric Cancer. 2016;19:403\u201311.","journal-title":"Gastric Cancer"},{"key":"2469_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/BC20060086","volume":"99","author":"J Tcherkezian","year":"2007","unstructured":"Tcherkezian J, Lamarche-Vane N. Current knowledge of the large RhoGAP family of proteins. Biol Cell. 2007;99:67\u201386.","journal-title":"Biol Cell"},{"key":"2469_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1080\/10409238.2020.1810622","volume":"55","author":"RG Hodge","year":"2020","unstructured":"Hodge RG, Schaefer A, Howard SV, Der CJ. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers? Crit Rev Biochem Mol Biol. 2020;55:386\u2013407.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2469_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.bbamem.2007.08.017","volume":"1778","author":"H Chiba","year":"2008","unstructured":"Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778:588\u2013600.","journal-title":"Biochim Biophys Acta"},{"key":"2469_CR42","doi-asserted-by":"publisher","first-page":"7947","DOI":"10.1038\/sj.onc.1208161","volume":"23","author":"AB Reynolds","year":"2004","unstructured":"Reynolds AB, Roczniak-Ferguson A. Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene. 2004;23:7947\u201356.","journal-title":"Oncogene"},{"key":"2469_CR43","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1038\/35070151","volume":"3","author":"Y Leverrier","year":"2001","unstructured":"Leverrier Y, Ridley AJ. Apoptosis: caspases orchestrate the ROCK \u2018n\u2019 bleb. Nat Cell Biol. 2001;3:E91\u201393.","journal-title":"Nat Cell Biol"},{"key":"2469_CR44","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","volume":"27","author":"YI Petrova","year":"2016","unstructured":"Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27:3233\u201344.","journal-title":"Mol Biol Cell"},{"key":"2469_CR45","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","volume":"37","author":"AM Mendonsa","year":"2018","unstructured":"Mendonsa AM, Na TY, Gumbiner BM. E-cadherin in contact inhibition and cancer. Oncogene. 2018;37:4769\u201380.","journal-title":"Oncogene"},{"key":"2469_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ncb3457","volume":"19","author":"MK Han","year":"2016","unstructured":"Han MK, de Rooij J. Resolving the cadherin-F-actin connection. Nat Cell Biol. 2016;19:14\u201316.","journal-title":"Nat Cell Biol"},{"key":"2469_CR47","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1182\/blood-2010-07-296913","volume":"117","author":"W Alduaij","year":"2011","unstructured":"Alduaij W, Ivanov A, Honeychurch J, Cheadle EJ, Potluri S, Lim SH, et al. Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood. 2011;117:4519\u201329.","journal-title":"Blood"},{"key":"2469_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nm1263","volume":"11","author":"G Kroemer","year":"2005","unstructured":"Kroemer G, Martin SJ. Caspase-independent cell death. Nat Med. 2005;11:725\u201330.","journal-title":"Nat Med"},{"key":"2469_CR49","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.1038\/onc.2008.310","volume":"27","author":"P Boya","year":"2008","unstructured":"Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene. 2008;27:6434\u201351.","journal-title":"Oncogene"},{"key":"2469_CR50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018;23:882\u201397.","journal-title":"Cell Stem Cell"},{"key":"2469_CR51","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/cr.2014.137","volume":"24","author":"Q Sun","year":"2014","unstructured":"Sun Q, Cibas ES, Huang H, Hodgson L, Overholtzer M. Induction of entosis by epithelial cadherin expression. Cell Res. 2014;24:1288\u201398.","journal-title":"Cell Res"},{"key":"2469_CR52","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jtho.2015.12.093","volume":"11","author":"HN Song","year":"2016","unstructured":"Song HN, Jung KS, Yoo KH, Cho J, Lee JY, Lim SH, et al. Acquired C797S mutation upon treatment with a T790M-specific third-generation EGFR inhibitor (HM61713) in non-small cell lung cancer. J Thorac Oncol. 2016;11:e45\u201347.","journal-title":"J Thorac Oncol"},{"key":"2469_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00268-009-0355-1","volume":"34","author":"T Fukagawa","year":"2010","unstructured":"Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, et al. Significance of lavage cytology in advanced gastric cancer patients. World J Surg. 2010;34:563\u20138.","journal-title":"World J Surg"},{"key":"2469_CR54","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Chiwaki F, Kojima S, Kawazu M, Komatsu M, Ueno T, et al. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer. 2021;2:962\u201377.","journal-title":"Nat Cancer"},{"key":"2469_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4:359\u201365.","journal-title":"Nat Methods"},{"key":"2469_CR56","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1074\/mcp.T500039-MCP200","volume":"5","author":"M Ono","year":"2006","unstructured":"Ono M, Shitashige M, Honda K, Isobe T, Kuwabara H, Matsuzuki H, et al. Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry. Mol Cell Proteom. 2006;5:1338\u201347.","journal-title":"Mol Cell Proteom"},{"key":"2469_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1349-7006.2008.01055.x","volume":"100","author":"A Negishi","year":"2009","unstructured":"Negishi A, Ono M, Handa Y, Kato H, Yamashita K, Honda K, et al. Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry. Cancer Sci. 2009;100:514\u20139.","journal-title":"Cancer Sci"},{"key":"2469_CR58","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7150\/thno.37623","volume":"10","author":"Y Abe","year":"2020","unstructured":"Abe Y, Hirano H, Shoji H, Tada A, Isoyama J, Kakudo A, et al. Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens. Theranostics. 2020;10:2115\u201329.","journal-title":"Theranostics"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02469-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02469-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:06:23Z","timestamp":1666443983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02469-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":58,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2022,10,21]]}},"alternative-id":["2469"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02469-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"17 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}